DDOG:NASDAQDatadog, Inc. Analysis
Data as of 2026-05-23 - not real-time
$222.32
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Datadog is trading at the top of its yearly range, comfortably above its short‑term moving averages. The price sits well above the 20‑day and 50‑day SMA, confirming a bullish technical backdrop. Momentum indicators are strongly positive, with the MACD line crossing above its signal and a widening histogram. However, the RSI has surged into extreme overbought territory, suggesting short‑term price pressure may build. Trading volume has been on a downtrend, which could limit the sustainability of the current rally. A beta above one indicates the stock moves more sharply than the market, amplifying both upside and downside moves. The market sentiment index is in the “Extreme Greed” zone, reflecting heightened investor enthusiasm.
Recent earnings news highlighted revenue breaking the one‑billion‑dollar mark, driven by AI‑focused product adoption and an upgraded full‑year outlook. The company posted a return to GAAP operating profitability and generated robust operating cash flow. Despite these fundamentals, the current price is well above the DCF‑derived fair value, resulting in an overvalued valuation grade. The forward PE remains very high relative to industry peers, while the dividend yield is zero, confirming a non‑dividend‑paying growth profile. Risk considerations include high volatility, sector‑specific competitive pressure, and regulatory scrutiny around data security. Overall, the stock presents a strong growth narrative but at a premium that warrants cautious positioning.
Recent earnings news highlighted revenue breaking the one‑billion‑dollar mark, driven by AI‑focused product adoption and an upgraded full‑year outlook. The company posted a return to GAAP operating profitability and generated robust operating cash flow. Despite these fundamentals, the current price is well above the DCF‑derived fair value, resulting in an overvalued valuation grade. The forward PE remains very high relative to industry peers, while the dividend yield is zero, confirming a non‑dividend‑paying growth profile. Risk considerations include high volatility, sector‑specific competitive pressure, and regulatory scrutiny around data security. Overall, the stock presents a strong growth narrative but at a premium that warrants cautious positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- price above short‑term moving averages
- bullish MACD crossover
- RSI in extreme overbought territory
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- strong revenue growth driven by AI
- robust cash generation and low debt
- upgraded guidance and operating profitability
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- long‑term demand for observability and security
- valuation premium relative to DCF
- high beta and sector competition
Key Metrics & Analysis
Financial Health
Revenue Growth32.20%
Profit Margin3.69%
P/E Ratio555.8
ROE3.93%
ROA-0.22%
Debt/Equity32.22
P/B Ratio19.8
Op. Cash Flow$1.1B
Free Cash Flow$936.7M
Industry P/E39.5
Technical Analysis
TrendBullish
RSI84.0
Support$128.00
Resistance$224.77
MA 20$179.54
MA 50$144.96
MA 200$141.91
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$103.36
Target Price$223.02
Upside/Downside0.31%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.24
Volatility85.21%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.